Fundraising FoxTVM Capital — Full Portfolio
9 tracked investments · listed companies and verified rows first
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications.
BiotechHealthtechMedical DevicesNew MaterialsBedford, US
James Biggins(Chief Executive Officer, President and Founder)inDennis Byrne(Chief Commercial Officer)inScott Blood(VP of Regulatory and Quality)inKatie Motherway(VP of Human Resources)inPaul Sabin(Director)Joseph Pellegrino(Director)
Board seatLuc Marengère· per SEC Form D
Co-investorsTVM Capital Life ScienceGreen Park & Golf Ventures
Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCarlsbad, US
Chris Villongco(Head of Technology / CTO)inRob Krummen(CEO (formerly President & COO))inKelly Perez(Head of Finance)inAlexander Michael Monko(Executive Officer, Director)
Board seatLuc Marengère· per SEC Form D · $37.5M raise · filed Feb 2024
Co-investorsSolas BioVenturesTVM Capital Life Science
RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis.
HealthtechMedical DevicesLutherville, US
Ellen Sheets(Executive Officer, Director)inIan J. Vawter(Executive Officer)Steven Schaefer(Executive Officer)inWilliam Floyd(Executive Officer, Director)inVincent Owens(Director)Richard Kent(Director)
Co-investorsAscension VenturesFirst AnalysisNew Markets Venture PartnersSV Health InvestorsBlue Heron CapitalTVM Capital Life Science
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures.
HardwareHealthtechMedical DevicesArden Hills, US
Robert F. Wilson(Founder & Chief Executive Officer)inJohn Gainor(Co-founder & Chief Technology Officer)inScott Youngstrom(Chief Financial Officer)inGavin Philipps(Chief Commercial Officer)in
BoardMarc Riviere(Director)Luc Marengere(Director)
Co-investorsJStar Capital InvestmentsTVM Capital Life Science
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Acer TherapeuticsCoLucid PharmaceuticalsAcanthasAurka PharmaCoLucid
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.